The following Guest editorial was provided by Richard Tren, Kimberly Hess, and Donald Roberts.
World Health Organization
This week WHO reiterated the fragility of the gains the world has made over the last decade through intense deployment of vector control in the fight against malaria. Reuters published an online article on the matter titled 'Insecticide resistance threatens malaria fight'. In it, WHO Director General, Margaret Chan, warns of the seriousness of the situation in Africa and India. Apparently, in ever more places the toolbox, filled with four classes of chemicals, is gradually emptying.
The Malaria Policy Advisory Committee to the World Health Organization met for the first time from 31 January to 2 February 2012 in Geneva, Switzerland.
The review by Cohen et al. suggests one possible future if such investment is not made. However, with sufficient support, malaria resurgences can be relegated to history.
This study was conducted to correlate blood concentrations of lumefantrine with treatment outcome for patients with Plasmodium falciparum malaria when the drug was given without specific instructions for administration with food.
We report a successful treatment of severe falciparum malaria in a non-immune adult patient with 30% parasitemia treated with the 6-dose oral regimen of artemether plus lumefantrine combination therapy alone.
The article below was written by Dr. Bill Jobin and first posted as a comment under the most recent poll. I elevated it to a Guest editorial.
It is unfortunate that we have recently seen a great deal of confusion about the amount of malaria in Africa. The confusion arises because most of the people making the estimates are not scientists but artists; computer artists. It would be better if we relied on scientists. Computer artists, using their own data and their own inspirations, get varying answers and generate conflicting maps and graphs. But scientists, using standardized techniques and randomized sampling, get the same answers, no matter who is doing the work. We urgently need accurate numbers on malaria...
Development and Phase 3 testing of the most advanced malaria vaccine, RTS,S/AS01, indicates that malaria vaccine R&D is moving into a new phase.
This article reviews the history of malaria and its eradication in the U.S. and discusses methods for laboratory diagnosis.
The focus of this study is to develop a robust, unsupervised and sensitive malaria screening technique with low material cost and one that has an advantage over other techniques in that it minimizes human reliance and is, therefore, more consistent in applying diagnostic criteria.